City
Epaper

FDA authorizes first-ever breathing test for detecting COVID-19 infection

By ANI | Updated: April 16, 2022 07:10 IST

The Food and Drug Administration (FDA) authorized the first test, InspectIR COVID-19 Breathalyzer, to detect COVID-19 through the breath for emergency use.

Open in App

The Food and Drug Administration (FDA) authorized the first test, InspectIR COVID-19 Breathalyzer, to detect COVID-19 through the breath for emergency use.

The InspectIR COVID-19 Breathalyzer uses a technique called gas chromatography gas mass-spectrometry (GC-MS) to separate and identify chemical mixtures and rapidly detect five Volatile Organic Compounds (VOCs) associated with SARS-CoV-2 infection in exhaled breath. When the InspectIR COVID-19 Breathalyzer detects the presence of VOC markers of SARS-CoV-2, a presumptive (unconfirmed) positive test result is returned and should be confirmed with a molecular test, FDA informed in a statement.

The InspectIR COVID-19 Breathalyzer which is about the size of a carry-on piece of luggage is able to identify five volatile organic compounds tied to the coronavirus in a person's breath using a technique known as gas chromatography gas mass-spectrometry, delivering results within three minutes, according to the FDA, the statement reads.

The agency said that in a study of 2,409 people, which included both people with and without symptoms, the test had a 99.3 per cent specificity rate, which measures the per cent of correctly identified negative test samples.

The FDA also noted that the InspectIR COVID-19 Breathalyzer had a 91.2 per cent sensitivity rate, which measures the per cent of correctly identified positive test samples.

However, the health agency said that a molecular test should be used to confirm positive test results returned by the COVID-19 breath test.

Jeff Shuren, director of the FDA's Center for Devices and Radiological Health, in a statement, said, "Today's authorization is yet another example of the rapid innovation occurring with diagnostic tests for COVID-19," as per The Hill.

Nearly 100 of the InspectIR COVID-19 Breathalyzers, each of which the FDA said can be used to test roughly 160 samples per day, are anticipated to be made each week.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Jeff shurenfdaFood And Drug AdministrationFood products, medicinesUnited states food and drug administrationCommissioner of food and drugs administrationUsfdaUnited states' food and drug administrationUnited states food & drug administrationU.s. food and drug administration
Open in App

Related Stories

PunePune: Action to Be Taken Against Use of Calcium Carbide to Ripen Mangoes

MumbaiMumbai: FDA Seizes Medicines Worth Rs 61.95 Lakh from Ghatkopar-Based Drug Firm

MumbaiMumbai: FDA Cracks Down on Adulterated Milk at City Entry Points; Over 1.5 Lakh Litres Inspected

NashikAdulterated Paneer in Nashik: FDA Raids Factory, Seizes 239 Kg Paneer Worth Rs 47,800 Ahead of Gudi Padwa and Eid

MaharashtraChandrapur Shops Caught Selling Fake Paneer; FDA Seizes 472 Kg of Cheese Analogue

International Realted Stories

InternationalAngolan President Lourenco to begin 4-day state visit to India today

InternationalTaiwan detects 34 sorties of Chinese aircraft, 8 naval vessels in its territory

InternationalDeal with India close but not there yet: Top US trade official

InternationalMiddle East's largest steel producer urges India to grant market access to Iranian firms

InternationalUS ask Pak to condemn Pahalgam terror attack, "de-escalate tensions" with India